Impact of Isovolemic Hemodilution‐Red Cell Exchange on Health‐Related Quality of Life in Patients With Sickle Cell Disease: A Pilot Study

Documenti analoghi

• A Pharmacist‐Managed Hydroxyurea Prescribing Protocol Improves Uptake and Optimization among Patients with Sickle Cell Disease
  di: Cameron Roessner, et al.
  Pubblicazione: (2024)
• Cerebral Fat Embolism Syndrome in Homozygous Sickle Cell Disease Treated With Therapeutic Plasma Exchange and Simple Transfusions
  di: Tyler Vajdic, et al.
  Pubblicazione: (2026)
• Legendary Case of Factitious Disorder Presenting as ‘Sickle Cell Disease’ Creates Challenges for All Medical Specialties
  di: Olivia Iverson, et al.
  Pubblicazione: (2025)
• Extracorporeal Blood Purification Therapy to Deal a Deferasirox Induced Life‐Threatening Hepatic Encephalopathy in a Septic Child With Sickle‐Cell Disease: A Case Report
  di: E. Rossetti, et al.
  Pubblicazione: (2025)
• Red Blood Cell Depletion in Patients With Hyperferritinemia: Comparison of Two Apheresis Systems
  di: Heidrun Neureiter, et al.
  Pubblicazione: (2026)